Citation 129027
POPIK,P: LAYER,RT: SKOLNICK,P:. (1995). 100 YEARS OF IBOGAINE: NEUROCHEMICAL AND PHARMACOLOGICAL ACTIONS OF A PUTATIVE ANTI-ADDICTIVE DRUG.. 47(2)
Citation Details
| Title | 100 YEARS OF IBOGAINE: NEUROCHEMICAL AND PHARMACOLOGICAL ACTIONS OF A PUTATIVE ANTI-ADDICTIVE DRUG. |
|---|---|
| Authors | POPIK,P: LAYER,RT: SKOLNICK,P: |
| Year | 1995 |
| Volume | 47 |
| Issue | 2 |
Summary
Year: 1995
Journal: Unknown
Organisms and Their Experiments (1)
Unknown organism
| Experiment # | Pharmacology Type | Worktypes | Compound | Results |
|---|---|---|---|---|
| 1 |
GLUTAMATE RECEPTOR BLOCKER
|
ACTIVE
|
||
| 2 |
OPIATE RECEPTOR BINDING INHIBITION
|
ACTIVE
|
||
| 3 |
ADRENERGIC RECEPTOR BLOCKER(BETA)
|
INACTIVE
|
||
| 4 |
ADRENERGIC RECEPTOR BLOCKER(ALPHA)
|
INACTIVE
|
||
| 5 |
SODIUM CHANNEL BINDING EFFECT
|
ACTIVE
|
||
| 6 |
GABA RECEPTOR BLOCKING EFFECT
|
INACTIVE
|
||
| 7 |
CHOLINESTERASE INHIBITION
|
ACTIVE
|
||
| 8 |
CALCIUM CHANNEL BINDING EFFECT
|
ACTIVE
|
||
| 9 |
SPASMOLYTIC ACTIVITY
|
ACTIVE
|
||
| 10 |
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
|
INACTIVE
|
||
| 11 |
OPIATE RECEPTOR BINDING INHIBITION
|
ACTIVE
|
||
| 12 |
DRUG ADDICTION INHIBITION
|
ACTIVE
|
||
| 13 |
DRUG ADDICTION INHIBITION
|
ACTIVE
|
||
| 14 |
DOPAMINE RECEPTOR BLOCKING EFFECT
|
INACTIVE
|
||
| 15 |
DOPAMINE DEPLETION
|
ACTIVE
|
||
| 16 |
APHRODISIAC ACTIVITY
|
ACTIVE
|
||
| 17 |
HALLUCINOGENIC ACTIVITY
|
ACTIVE
|
||
| 18 |
CNS EFFECTS(GENERAL)
|
ACTIVE
|
||
| 19 |
CNS EFFECTS(GENERAL)
|
ACTIVE
|
||
| 20 |
ANTINEUROTOXIC ACTIVITY
|
ACTIVE
|
||
| 21 |
NEUROTOXIC ACTIVITY
|
ACTIVE
|
||
| 22 |
TOXIC EFFECT(GENERAL)
|
INACTIVE
|
||
| 23 |
TOXICITY ASSESSMENT(QUANTITATIVE)
|
.
|
||
| 24 |
TOXICITY ASSESSMENT(QUANTITATIVE)
|
.
|
||
| 25 |
TOXICITY ASSESSMENT(QUANTITATIVE)
|
.
|
||
| 26 |
ANTIFATIGUE ACTIVITY
|
ACTIVE
|
||
| 27 |
HALLUCINOGENIC ACTIVITY
|
ACTIVE
|
||
| 28 |
CNS STIMULANT ACTIVITY
|
ACTIVE
|
||
| 29 |
ANXIETY INDUCTION
|
ACTIVE
|
||
| 30 |
ANTIBRADYCARDIA ACTIVITY
|
ACTIVE
|
||
| 31 |
CHRONOTROPIC EFFECT NEGATIVE
|
ACTIVE
|
||
| 32 |
CNS STIMULANT ACTIVITY
|
ACTIVE
|
||
| 33 |
TREMORIGENIC ACTIVITY
|
ACTIVE
|
||
| 34 |
ATAXIA
|
ACTIVE
|
||
| 35 |
CNS STIMULANT ACTIVITY
|
ACTIVE
|
||
| 36 |
PHARMACOKINETIC STUDY OF
|
ACTIVE
|